ClearDose MS: next-infusion rescue board for neurology clinics

Idea Overview

TLDR

Source section: TLDR
01

ProblemNeurology infusion teams keep rescuing patients who look booked for the next Ocrevus, Tysabri, Briumvi, or Lemtrada dose but are still blocked by expiring prior auth, site-of-care changes, pharmacy routing failures, or stale documentation.

02

SolutionClearDose MS reads payer letters, infusion schedules, and coordinator inboxes, then sorts the next-dose queue into ready, expiring, blocked, and reroute cases with blocker tags such as 12-month reauth due, G35 code mismatch, or white-bagging reset.

03

Market opportunityMS therapeutics reached $34.80B in 2025, IV infusion represented $9.05B, and neurology EMR budgets already run about $150-$395 per provider per month, leaving room for an $800-$2,000 monthly continuity desk.

Source file content is presented without editorial changes.